Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Water proton relaxation enhancement by chelated gadolinium refers to the process whereby gadolinium-based contrast agents, when chelated to reduce toxicity, act as highly efficient paramagnetic centers in MRI. These agents accelerate the relaxation of nearby water protons, most notably decreasing longitudinal (T1) relaxation time, resulting in brighter signal on T1-weighted MR images. The mechanism centers on inner-sphere and outer-sphere relaxation effects, where water molecules directly interact with the Gd(III) ion, or are affected at further distances. This property underpins the use of gadolinium-chelates as MRI contrast agents, which are not therapeutic targets but are essential tools for diagnostic imaging. Major safety issues include risk of nephrogenic systemic fibrosis and concerns over gadolinium deposition/retention, especially with repeated dosing, and they are contraindicated in pregnancy except in unusual cases.
Paramagnetic shortening of water proton T1 (and to a lesser extent, T2) relaxation times, leading to MRI signal enhancement in tissues where the contrast agent is present
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Water proton relaxation enhancement by chelated gadolinium.